Halozyme Therapeutics (HALO) Valuation Check As Recent Share Pullback Follows Strong Multi Year Returns [Yahoo! Finance]
Halozyme Therapeutics, Inc. (HALO)
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
halozyme.com/investors/default.aspx
Company Research
Source: Yahoo! Finance
Halozyme Therapeutics (HALO) has drawn attention after recent share moves, with the stock showing a small 1 day decline and a modest 7 day and month pullback, while the past 3 months remain positive. See our latest analysis for Halozyme Therapeutics. At a share price of $69.40, Halozyme Therapeutics is giving back some recent gains, with short term share price returns softening. However, longer term total shareholder returns over 1, 3 and 5 years remain firmly positive, suggesting earlier momentum is now cooling. If Halozyme's recent moves have you reassessing your watchlist, it could be a good moment to widen your search with our screener of 31 healthcare AI stocks and see what else stands out. With Halozyme's shares easing after strong multi year returns, yet trading below the average analyst price target and an indicated intrinsic value, you have to ask: is this a reasonable entry point, or is future growth already priced in? Most Popular Narrative: 17.9% Undervalued A
Show less
Read more
Impact Snapshot
Event Time:
HALO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HALO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HALO alerts
High impacting Halozyme Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
HALO
News
- Is Halozyme Therapeutics (HALO) Pricing Reflect Long Term Prospects After Recent Share Pullback [Yahoo! Finance]Yahoo! Finance
- Halozyme Therapeutics, Inc. (HALO) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]Seeking Alpha
- Is Halozyme Therapeutics (HALO) a Buy Post Earnings? [Yahoo! Finance]Yahoo! Finance
- Halozyme Therapeutics, Inc. (HALO): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Halozyme Therapeutics (HALO) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "buy (b-)" to "hold (c)".MarketBeat
HALO
Earnings
- 2/17/26 - Miss
HALO
Sec Filings
- 3/4/26 - Form 4
- 2/24/26 - Form 4
- 2/24/26 - Form 4
- HALO's page on the SEC website